HomeCompareENTEF vs MRK

ENTEF vs MRK: Dividend Comparison 2026

ENTEF yields 8333.33% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ENTEF wins by $9167747390577058.00M in total portfolio value
10 years
ENTEF
ENTEF
● Live price
8333.33%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9167747390577058.00M
Annual income
$8,956,326,004,308,616,000,000.00
Full ENTEF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ENTEF vs MRK

📍 ENTEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodENTEFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ENTEF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ENTEF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ENTEF
Annual income on $10K today (after 15% tax)
$708,333.33/yr
After 10yr DRIP, annual income (after tax)
$7,612,877,103,662,324,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ENTEF beats the other by $7,612,877,103,662,324,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ENTEF + MRK for your $10,000?

ENTEF: 50%MRK: 50%
100% MRK50/50100% ENTEF
Portfolio after 10yr
$4583873695288529.00M
Annual income
$4,478,163,002,154,308,000,000.00/yr
Blended yield
97.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ENTEF
No analyst data
Altman Z
-17.7
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ENTEF buys
0
MRK buys
0
No recent congressional trades found for ENTEF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricENTEFMRK
Forward yield8333.33%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$9167747390577058.00M$56.8K
Annual income after 10y$8,956,326,004,308,616,000,000.00$9,798.13
Total dividends collected$9153631700876960.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ENTEF vs MRK ($10,000, DRIP)

YearENTEF PortfolioENTEF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$844,033$833,333.33$11,206$366.19+$832.8KENTEF
2$66,637,799$65,734,683.28$12,650$502.35+$66.63MENTEF
3$4,921,638,642$4,850,336,197.34$14,407$694.19+$4921.62MENTEF
4$340,059,751,219$334,793,597,872.29$16,585$967.82+$340059.73MENTEF
5$21,983,026,935,088$21,619,163,001,283.26$19,342$1,363.89+$21983026.92MENTEF
6$1,329,654,704,481,797$1,306,132,865,661,252.20$22,913$1,947.19+$1329654704.46MENTEF
7$75,256,486,591,502,860$73,833,756,057,707,330.00$27,662$2,823.89+$75256486591.48MENTEF
8$3,986,020,907,319,540,000$3,905,496,466,666,632,000.00$34,159$4,173.35+$3986020907319.51MENTEF
9$197,590,080,624,712,480,000$193,325,038,253,880,570,000.00$43,337$6,308.80+$197590080624712.44MENTEF
10$9,167,747,390,577,058,000,000$8,956,326,004,308,616,000,000.00$56,776$9,798.13+$9167747390577058.00MENTEF

ENTEF vs MRK: Complete Analysis 2026

ENTEFStock

ESE Entertainment Inc., an entertainment and technology company, focuses on gaming and esports in Europe and internationally. It consists of multiple assets and operators in the gaming and esports industries. The company's capabilities include physical infrastructure, broadcasting, global distribution for gaming and esports-related content, advertising, simulation racing business unit, and a growing esport team franchise, as well as K1CK Esports. It also engages in the infrastructure business that manages fan engagement for OTT and esports; and provision of gaming related infrastructure, technology, and support. In addition, the company offers out-sourced network services; operates telecommunications network; turnkey simulator packages; builds bespoke simulators; and Virtual Pitstop technology for video game developers, racing fans, and gamers to engage in motorsport related esports. It serves video game developers, publishers, and brands. The company was formerly known as Kepler Acquisition Corp. and changed its name to ESE Entertainment Inc. in August 12, 2020. ESE Entertainment Inc. was founded in 2019 and is headquartered in Vancouver, Canada.

Full ENTEF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ENTEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ENTEF vs SCHDENTEF vs JEPIENTEF vs OENTEF vs KOENTEF vs MAINENTEF vs JNJENTEF vs ABBVENTEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.